Details der Publikation - Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle

Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle

Abstract Foot-and-mouth disease (FMD) is a highly contagious and economically important viral disease of cloven-hoofed animals. Routine vaccination is one of the preferred methods of protection against this disease in endemic countries. For protective immunity against FMD, repeated immunizations with frequent administration are required. Intradermal immunization has many advantages over intramuscular administration of vaccines. In this study, a commercial tetravalent FMD vaccine adjuvanted with Montanide ISA 206 was administered to cattle via the intramuscular (2 mL [n = 10] and 0.5 mL [n = 9]) and intradermal (0.5 mL [n = 11]) routes. Booster doses were administered 28 days later using the same vaccine and routes. Serum samples were collected on days 0, 7, 14, and 28 post-vaccination (pv) and at 30 and 60 days post-booster. Homologous and heterologous virus neutralization tests and liquid-phase blocking and isotype ELISAs were used to measure the antibody response. The results showed that intradermal administration of quarter doses of the vaccine provides an equal or better virus neutralization antibody response than intramuscular administration of the same dose of vaccine after booster administration in cattle. This means that four times more cattle can be immunized with the same amount of vaccine using the intradermal route without compromising immunity..

Medienart:	E-Artikel

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Zur Gesamtaufnahme - volume:167
Enthalten in:	Archives of virology - 167(2022), 2 vom: 16. Jan., Seite 405-413

Sprache:	Englisch

Beteiligte Personen:	Çokçalışkan, Can [VerfasserIn] Tuncer-Göktuna, Pelin [VerfasserIn] Sareyyüpoğlu, Beyhan [VerfasserIn] Türkoğlu, Tunçer [VerfasserIn] Yıldız, Muhammet [VerfasserIn] Deveci, M. Nuri Fırat [VerfasserIn] Aras-Uzun, Eylem [VerfasserIn] Arslan, Abdullah [VerfasserIn] Kürkçü, Ayça [VerfasserIn] Uzunlu, Ergün [VerfasserIn] Asar, Erdoğan [VerfasserIn]

Links:	Volltext [lizenzpflichtig]

RVK:	RVK Klassifikation ELIB24 ELIB09

Anmerkungen:	© The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021

doi:	10.1007/s00705-021-05273-x

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	OLC212942158X

Internformat


LEADER	01000naa a22002652 4500
001	OLC212942158X
003	DE-627
005	20230505221110.0
007	cr uuu---uuuuu
008	230505s2022 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/s00705-021-05273-x \|2 doi
035			\|a (DE-627)OLC212942158X
035			\|a (DE-He213)s00705-021-05273-x-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a ELIB24 \|q VZ \|2 rvk
084			\|a ELIB09 \|q VZ \|2 rvk
100	1		\|a Çokçalışkan, Can \|e verfasserin \|0 (orcid)0000-0002-3839-0986 \|4 aut
245	1	0	\|a Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle
264		1	\|c 2022
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021
520			\|a Abstract Foot-and-mouth disease (FMD) is a highly contagious and economically important viral disease of cloven-hoofed animals. Routine vaccination is one of the preferred methods of protection against this disease in endemic countries. For protective immunity against FMD, repeated immunizations with frequent administration are required. Intradermal immunization has many advantages over intramuscular administration of vaccines. In this study, a commercial tetravalent FMD vaccine adjuvanted with Montanide ISA 206 was administered to cattle via the intramuscular (2 mL [n = 10] and 0.5 mL [n = 9]) and intradermal (0.5 mL [n = 11]) routes. Booster doses were administered 28 days later using the same vaccine and routes. Serum samples were collected on days 0, 7, 14, and 28 post-vaccination (pv) and at 30 and 60 days post-booster. Homologous and heterologous virus neutralization tests and liquid-phase blocking and isotype ELISAs were used to measure the antibody response. The results showed that intradermal administration of quarter doses of the vaccine provides an equal or better virus neutralization antibody response than intramuscular administration of the same dose of vaccine after booster administration in cattle. This means that four times more cattle can be immunized with the same amount of vaccine using the intradermal route without compromising immunity.
700	1		\|a Tuncer-Göktuna, Pelin \|0 (orcid)0000-0002-7468-0155 \|4 aut
700	1		\|a Sareyyüpoğlu, Beyhan \|0 (orcid)0000-0002-0279-1673 \|4 aut
700	1		\|a Türkoğlu, Tunçer \|0 (orcid)0000-0002-6780-6186 \|4 aut
700	1		\|a Yıldız, Muhammet \|4 aut
700	1		\|a Deveci, M. Nuri Fırat \|4 aut
700	1		\|a Aras-Uzun, Eylem \|0 (orcid)0000-0001-5845-4791 \|4 aut
700	1		\|a Arslan, Abdullah \|0 (orcid)0000-0001-7985-4970 \|4 aut
700	1		\|a Kürkçü, Ayça \|0 (orcid)0000-0002-6411-917X \|4 aut
700	1		\|a Uzunlu, Ergün \|0 (orcid)0000-0002-0509-7257 \|4 aut
700	1		\|a Asar, Erdoğan \|0 (orcid)0000-0002-6987-7068 \|4 aut
773	0	8	\|i Enthalten in \|t Archives of virology \|d Springer Vienna, 1939 \|g 167(2022), 2 vom: 16. Jan., Seite 405-413 \|h Online-Ressource \|w (DE-627)253390168 \|w (DE-600)1458460-8 \|w (DE-576)072283327 \|x 1432-8798 \|7 nnns
773	1	8	\|g volume:167 \|g year:2022 \|g number:2 \|g day:16 \|g month:01 \|g pages:405-413
856	4	0	\|u https://dx.doi.org/10.1007/s00705-021-05273-x \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_OLC
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_95
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_120
912			\|a GBV_ILN_138
912			\|a GBV_ILN_150
912			\|a GBV_ILN_151
912			\|a GBV_ILN_152
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_171
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_250
912			\|a GBV_ILN_252
912			\|a GBV_ILN_267
912			\|a GBV_ILN_281
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_636
912			\|a GBV_ILN_702
912			\|a GBV_ILN_711
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2031
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2037
912			\|a GBV_ILN_2038
912			\|a GBV_ILN_2039
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2057
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2065
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2093
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2107
912			\|a GBV_ILN_2108
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2113
912			\|a GBV_ILN_2118
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2132
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2144
912			\|a GBV_ILN_2147
912			\|a GBV_ILN_2148
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2188
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2336
912			\|a GBV_ILN_2433
912			\|a GBV_ILN_2446
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2474
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_2522
912			\|a GBV_ILN_2548
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4046
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4246
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4328
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4335
912			\|a GBV_ILN_4336
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	r	v	\|a ELIB24
936	r	v	\|a ELIB09
951			\|a AR
952			\|d 167 \|j 2022 \|e 2 \|b 16 \|c 01 \|h 405-413

Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände